Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPVG.L Regulatory News (PVG)

  • There is currently no data for PVG

Re EGM

13 Aug 2010 16:24

RNS Number : 0819R
Ark Therapeutics Group PLC
13 August 2010
 



ARK THERAPEUTICS GROUP PLC (the "Company")

 

POSTPONEMENT OF EXTRAORDINARY GENERAL MEETING ("EGM")

 

In light of representations made to the Company by a number of shareholders, in part prompted by unavailability over the summer holiday season, the Board has taken the decision to reschedule the EGM from 11.00 a.m. on 19 August 2010 to 12 noon on 6 September 2010. The location of the EGM will not change.

 

This will, in addition, allow the Board to convene and consider in detail the next steps in the implementation of its strategy, informed by its discussions with Iain Ross who has spent the recent weeks working alongside management undertaking a wholesale review of the Group's business and operations. The Board wishes to inform shareholders of the outcome of those deliberations in advance of the EGM and will, therefore, provide a further update as part of its half-yearly report, which is scheduled to be released on 25 August.

 

In accordance with the Articles, the Board shall provide details of the postponed EGM in two UK national newspapers.

 

EGM Deadline and Voting Formalities

 

The current forms of proxy remain valid. The new deadline for the written forms of proxy must be submitted by 12 noon on 2 September 2010. Forms of proxy that have been validly submitted by shareholders to date shall remain valid for the postponed EGM.

 

Save as expressly stated in this document, the contents of the original notice of extraordinary general meeting, including without limitation the business to be conducted at the meeting and the Board's recommendation, shall be unchanged. Words and expressions defined in the original notice for the EGM, shall, unless the context otherwise requires, have the same meaning when read in this document. All other terms and provisions of the Company's original notice for the EGM along with the forms of proxy (all dated 28 July 2010) shall apply. For further details and copies of the relevant documents, please go to www.arktherapeutics.com.

 

A letter has been sent to the Company's shareholders setting out the information above, two copies of which have been sent to the UK Listing Authority Document Viewing Facility and will be available for viewing shortly.

 

 

 

For further information:

 

Ark Therapeutics Group plc

Tel: + 44 (0)20 7388 7722

Martyn Williams, CEO

 

Andrew Christie, Chairman

 

 

 

Financial Dynamics

Tel: +44 (0)20 7831 3113

Ben Atwell

 

Susan Quigley

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBUGDIXDBBGGX
Date   Source Headline
13th Jul 200610:26 amRNSHolding(s) in Company
27th Jun 20063:34 pmRNSHolding(s) in Company
21st Jun 20067:01 amRNSRe Agreement
9th Jun 20061:58 pmRNSHolding(s) in Company
5th Jun 20063:44 pmRNSBlocklisting Interim Review
22nd May 20063:52 pmRNSDirectors' Shareholdings
19th May 20063:13 pmRNSRe Placing and Open Offer
27th Apr 20063:29 pmRNSResult of AGM
27th Apr 20067:03 amRNSPlacing and Open Offer
30th Mar 20067:01 amRNSRe Agreement
28th Mar 20063:22 pmRNSAnnual Information Update
9th Mar 20067:02 amRNSFinal Results
24th Feb 20064:44 pmRNSOption Awards
15th Feb 20067:01 amRNSRe Agreement
9th Feb 200611:18 amRNSDirector Share Dealing
19th Jan 200611:12 amRNSNotice of Results
16th Jan 20067:01 amRNSResearch Update
12th Jan 20067:00 amRNSUS Patent for Kerraboot
3rd Nov 20057:01 amRNSGrant for New Facility
28th Oct 20057:01 amRNSResearch Update
28th Oct 20057:01 amRNSRegulatory Application
28th Oct 20057:01 amRNSResearch Update
20th Oct 20057:00 amRNSArk Granted Licence
18th Oct 20057:00 amRNSResearch Update
5th Oct 20057:00 amRNSoxLDL approval
13th Sep 20054:37 pmRNSHolding(s) in Company
9th Sep 20055:00 pmRNSHolding(s) in Company
9th Sep 20053:46 pmRNSHolding(s) in Company
31st Aug 20057:01 amRNSInterim Results
24th Aug 20055:56 pmRNSHolding(s) in Company
5th Aug 20057:00 amRNSResearch Update
29th Jul 20056:00 pmRNSHolding(s) in Company
28th Jul 20053:48 pmRNSNotice of Results
25th Jul 20055:28 pmRNSInterest in Shares
21st Jul 20057:01 amRNSResearch Update
7th Jul 20057:00 amRNSBoard Appointment
23rd Jun 20058:41 amRNSDirector Shareholding
21st Jun 20057:00 amRNSResearch Update
14th Jun 20057:00 amRNSSigns Marketing Deal
8th Jun 20054:41 pmRNSListing Applications
7th Jun 20053:40 pmRNSHolding(s) in Company
19th May 20057:00 amRNSKerraboot Marketing Deal
4th May 20057:00 amRNSStrengthened Patent Position
3rd May 20056:11 pmRNSHolding(s) in Company
28th Apr 20054:25 pmRNSDoc re. Result of AGM
14th Apr 20057:00 amRNSResearch Update
7th Apr 20057:00 amRNSAppointment
1st Apr 20052:43 pmRNSNotice of AGM
1st Apr 20057:00 amRNSRe Agreement
23rd Mar 20057:00 amRNSResearch Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.